Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,722,100
Closed -$497M 5292
2025
Q4
$497M Buy
4,722,100
+4,061,900
+615% +$381M 0.12% 123
2025
Q3
$55.4M Buy
660,200
+609,900
+1,213% +$50.2M 0.01% 723
2025
Q2
$3.98M Sell
50,300
-199,700
-80% -$15.9M ﹤0.01% 2316
2025
Q1
$22.4M Buy
250,000
+245,200
+5,108% +$22.9M 0.01% 973
2024
Q4
$478K Hold
4,800
﹤0.01% 3848
2024
Q3
$545K Sell
4,800
-149,600
-97% -$17.8M ﹤0.01% 3722
2024
Q2
$19.1M Buy
154,400
+81,500
+112% +$10.5M 0.01% 953
2024
Q1
$9.62M Sell
72,900
-69,700
-49% -$8.59M ﹤0.01% 1418
2023
Q4
$15.5M Buy
+142,600
New +$14.8M 0.01% 1196
2023
Q2
Sell
-325,900
Closed -$34.7M 4887
2023
Q1
$34.7M Buy
325,900
+7,900
+2% +$853K 0.02% 620
2022
Q4
$35.3M Buy
318,000
+262,600
+474% +$26.8M 0.02% 634
2022
Q3
$4.77M Buy
55,400
+42,000
+313% +$3.75M 0.01% 1198
2022
Q2
$1.22M Buy
+13,400
New +$1.19M ﹤0.01% 2199
2022
Q1
Sell
-465,500
Closed -$35.7M 5383
2021
Q4
$35.7M Buy
465,500
+408,200
+712% +$32.5M 0.01% 694
2021
Q3
$4.3M Buy
57,300
+55,000
+2,391% +$4.18M ﹤0.01% 1733
2021
Q2
$179K Sell
2,300
-89,400
-97% -$6.65M ﹤0.01% 3604
2021
Q1
$6.75M Sell
91,700
-282,646
-76% -$20.8M ﹤0.01% 1282
2020
Q4
$29.2M Buy
374,346
+107,316
+40% +$8.21M 0.02% 663
2020
Q3
$21.1M Sell
267,030
-199,120
-43% -$15.6M 0.01% 720
2020
Q2
$34.4M Sell
466,150
-167,785
-26% -$12.6M 0.03% 434
2020
Q1
$46.5M Buy
633,935
+223,224
+54% +$17.5M 0.04% 332
2019
Q4
$35.6M Sell
410,711
-334,731
-45% -$27.5M 0.02% 654
2019
Q3
$59.9M Buy
745,442
+71,997
+11% +$5.77M 0.04% 388
2019
Q2
$53.9M Sell
673,445
-156,676
-19% -$12M 0.03% 458
2019
Q1
$65.9M Sell
830,121
-150,493
-15% -$11.3M 0.05% 364
2018
Q4
$71.5M Buy
980,614
+190,527
+24% +$13.4M 0.06% 259
2018
Q3
$53.5M Buy
790,087
+318,697
+68% +$20.3M 0.04% 384
2018
Q2
$27.3M Sell
471,390
-195,557
-29% -$11M 0.02% 630
2018
Q1
$34.7M Buy
666,947
+153,532
+30% +$8.29M 0.03% 575
2017
Q4
$27.6M Buy
513,415
+298,261
+139% +$16.5M 0.02% 643
2017
Q3
$13.1M Sell
215,154
-408,825
-66% -$24.8M 0.01% 886
2017
Q2
$38.2M Sell
623,979
-148,607
-19% -$9.05M 0.04% 366
2017
Q1
$46.8M Buy
772,586
+615,596
+392% +$37.3M 0.05% 268
2016
Q4
$8.82M Sell
156,990
-237,058
-60% -$13.9M 0.01% 1018
2016
Q3
$23.5M Sell
394,048
-78,390
-17% -$4.58M 0.03% 484
2016
Q2
$26M Buy
472,438
+114,336
+32% +$6.09M 0.03% 416
2016
Q1
$17.8M Sell
358,102
-683,820
-66% -$33.5M 0.03% 517
2015
Q4
$51.7M Buy
1,041,922
+361,875
+53% +$18.2M 0.06% 271
2015
Q3
$31.8M Sell
680,047
-32,593
-5% -$1.73M 0.04% 409
2015
Q2
$38.1M Sell
712,640
-138,546
-16% -$7.77M 0.04% 388
2015
Q1
$46.3M Sell
851,186
-145,672
-15% -$8.25M 0.05% 356
2014
Q4
$53.3M Sell
996,858
-308,321
-24% -$17.2M 0.05% 334
2014
Q3
$73.5M Buy
1,305,179
+6,812
+0.5% +$383K 0.07% 226
2014
Q2
$70.6M Buy
1,298,367
+429,889
+49% +$23.5M 0.07% 217
2014
Q1
$46.4M Sell
868,478
-1,973,384
-69% -$102M 0.05% 320
2013
Q4
$136M Buy
2,841,862
+1,236,116
+77% +$56.5M 0.14% 106
2013
Q3
$72M Sell
1,605,746
-266,296
-14% -$12.2M 0.09% 197
2013
Q2
$83M Buy
+1,872,042
New +$83.6M 0.1% 145

Other funds holding MRK

Barclays's MRK Position: Q1 2026 in Review

Barclays increased its Merck (MRK) stake by 58% in Q1 2026, buying an estimated $321M and bringing the position to 7,557,518 shares worth $909M. The position accounts for 0.22% of the portfolio, ranked #64.

Barclays first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.14B in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Barclays held 7,557,518 shares of Merck worth $909M as of Q1 2026.
  • Barclays bought 2,783,832 Merck shares in Q1 2026, an estimated $321M.
  • Merck made up 0.22% of Barclays's portfolio in Q1 2026, its #64 holding.
  • Barclays first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Merck position peaked at $1.14B in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.